profit from every $100 of sales.
$0$100
Nature's Sunshine Products
$10.31-5.67% today
-48.4% in 1 year
1-year low $10.261-year high $27.80
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay $9.15 for every $1 of profit it makes in a year.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Nature's Sunshine Products sold, what it kept, and what it did with the cash.
Sales went from $422 million in 2022 to $480 million in 2025, with $19.5 million of profit last year.
SalesProfit
Nature's Sunshine Products handed back 57% of the cash it generated last year.
Buybacks $16M
Free cash flow 2025$29M
Bought back its own shares$16M
Paid as dividends–
Cash vs. debt$94M vs. $19M
Nature's Sunshine Products vs. similar companies
Nature's Sunshine Products grows in the middle of these 5 and is the cheapest for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Nature's Sunshine Products | 9.2× · Cheap | ||
 Nestlé | 24.5× · Fair price | ||
 Danone | 24.0× · Fair price | ||
 JBS | 20.2× · Fair price | ||
 Foshan Haitian Flavouring and Food | 28.7× · Fair price |
AI analysis
An AI analyst reads Nature's Sunshine Products's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 422 | 445 | 454 | 480 | |
| 300 | 321 | 325 | 348 | |
| 16 | 19 | 20 | 25 | |
| 26 | 32 | 33 | 44 | |
| -0 | 15 | 8 | 20 | |
| -0.02 | 0.77 | 0.40 | 1.06 | |
| 71.0% | 72.1% | 71.5% | 72.4% | |
| 3.9% | 4.2% | 4.4% | 5.2% | |
| -0.1% | 3.4% | 1.7% | 4.1% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 230 | 250 | 241 | 261 |
| Cash | 60 | 82 | 85 | 94 |
| Total debt | 19 | 15 | 14 | 19 |
| Total liabilities | 83 | 90 | 80 | 100 |
| 143 | 154 | 155 | 162 | |
| 19 | 19 | 19 | 18 | |
| 7.5% | 9.5% | 8.7% | 13.1% | |
| -0.3% | 9.8% | 5.0% | 12.1% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 1 | 41 | 25 | 35 | |
| 8 | 10 | 11 | 6 | |
| -7 | 31 | 14 | 29 | |
| Dividends paid | 0 | – | – | – |
| 14 | 6 | 9 | 16 | |
| 3 | 5 | 5 | 6 |
Valuation
- 9.2×
- 9.2×
- –
- 2.3×
- 0.4×
- 6.2×
- 2.4×
- 16.1%
- 10.9%
- 0.0%
Profitability
- 72.4%
- 5.2%
- 4.1%
- 9.4%
- 9.7%
- 8.0%
- 12.3%
- 7.6%
- 14.8%
- –
Growth
- +4.4%
- –
- +101.3%
- +20.1%
- −2.4%
Financial health
- -1.4×
- 0.13
- 8.6%
- 1,757.3×
- 2.50
- 1.56
- 1.87
How it ranks in Consumer Staples
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 49%of 670
Bottom 24%of 674
Top 12%of 624
Bottom 42%of 673
Top 9%of 668
What analysts expect
- Average price target
- $19.50
- Range
- $18.00 – $21.00
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 7, 2026 | 0.30 | 0.21 | +46.3% |
| Mar 10, 2026 | 0.30 | 0.19 | +62.2% |
| Nov 6, 2025 | 0.36 | 0.19 | +89.5% |
| Jul 31, 2025 | 0.35 | 0.18 | +94.4% |
| May 6, 2025 | 0.25 | 0.17 | +47.1% |
| Mar 11, 2025 | -0.02 | 0.20 | −110.0% |
| Nov 7, 2024 | 0.23 | 0.14 | +64.3% |
| Aug 8, 2024 | 0.07 | 0.25 | −72.0% |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
3/7Passes 3 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
69Pass
Benjamin Graham
64Pass
Philip Fisher
56No pass
Peter Lynch
47No pass
Joel Greenblatt
61Pass
Charlie Munger
56No pass
Terry Smith
54No pass
Questions about Nature's Sunshine Products
Is Nature's Sunshine Products a good stock to buy?
A business with weak numbers, and the price looks low. 3 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Nature's Sunshine Products AI analysis
What does Nature's Sunshine Products do?
Nature's Sunshine Products, Inc., a natural health and wellness company, primarily manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It is in Packaged Foods.
Does Nature's Sunshine Products pay a dividend?
No. Nature's Sunshine Products does not pay a dividend at the moment; in 2025 it returned $16.3 million to shareholders by buying back its own shares.
Is Nature's Sunshine Products stock halal?
No. Nature's Sunshine Products does not pass our halal screen: its cash and confirmed interest-bearing investments are 53% of its market value, at or above the 33% limit. How we check
How has Nature's Sunshine Products stock done over the past year?
Down 48.4% over the past twelve months, to $10.31. It traded between $10.26 and $27.80 and is 62.9% below its high.
Who are Nature's Sunshine Products's competitors?
The largest listed companies in the same industry are Nestlé, Danone, JBS and Foshan Haitian Flavouring and Food. The peers table on this page compares their profit, growth and price with Nature's Sunshine Products's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.